Reji THOMAS, Mesut CETİN, Glen B. BAKER, M. Serdar DURSUN

Comment on FDA's Breakthrough Therapy Designation of Intranasal Esketamine for the Treatment of Major Depressive Disorder with Imminent Risk of Suicide

Comment on FDA's Breakthrough Therapy Designation of Intranasal Esketamine for the Treatment of Major Depressive Disorder with Imminent Risk of Suicide

Klinik Psikofarmakoloji Bülteni

2016-Cilt: 26 - Sayı: 4

329-331

211

Benzer Makaleler

Is depression a predictive factor for polypharmacy in elderly?

Klinik Psikofarmakoloji Bülteni

Mehmet YURUYEN, Hakan YAVUZER, Filiz DEMİRDAG, Zehra KARA, Serap YAVUZER, Alper DOVENTAS, Deniz Suna ERDİNCLER, Tanju BEGER, Mahir CENGİZ

Eosinophilic Myocarditis in Long Term Use of Antipsychotics: Case Series and Review of the Literature

Klinik Psikofarmakoloji Bülteni

Hanife Alkurt ALKAN, Sultan PEHLİVAN, Dilhan TURKKAN, Dogus Ozdemir KARA, Ahmet ŞAHPAZ

Acute Urinary Retention Related with Sublingual Buprenorphine Administration

Klinik Psikofarmakoloji Bülteni

Neslihan ALTUNSOY, Asli Enez DARCİN, Nesrin DİLBAZ

Psychotic Disorder or Complex Partial Seizure Disorder Due to a Sequelae of Herpes Simplex Encephalitis and Coincidental Parasagittal Meningioma

Klinik Psikofarmakoloji Bülteni

Elif AKCAY, Filiz KARADAG, Tugba TUNC

Turkish version of Acceptance and Action Questionnaire-II (AAQ-II): A reliability and validity analysis in clinical and non-clinical samples

Klinik Psikofarmakoloji Bülteni

Fatih YAVUZ, Sevinc ULUSOY, Mehtap ISKİN, Fatma Betul ESEN, Huseyin Sehid BURHAN, Mehmet Emrah KARADERE, Nuran YAVUZ

Valproate-induced hyperammonemic encephalopathy in a patient with ischemic stroke

Klinik Psikofarmakoloji Bülteni

Susan SOLOMON, Ramanathan SİNGARAVELU

Neuroinflammation in Schizophrenia: A Critical Review and The Future

Klinik Psikofarmakoloji Bülteni

Feyza ARİCİOGLU, Ceren Sahin OZKARTAL, Gokhan UNAL, Serdar DURSUN, Mesut CETİN, Norbert MÜLLER

Restless Leg Syndrome Associated with Aripiprazole

Klinik Psikofarmakoloji Bülteni